Your browser doesn't support javascript.
loading
The first case of third-generation cephalosporins resistant Kluyvera ascorbata biliary tract infection in Japan: A case report and review of the literature.
Mutoh, Yoshikazu; Kobe, Tomohisa; Hirano, Tomoya; Ichihara, Toshihiko; Takenaka, Hiroyuki; Niinomi, Takuro; Umemura, Takumi; Kuroiwa, Masanori.
Affiliation
  • Mutoh Y; Department of Infectious Diseases, Tosei General Hospital, Seto, Aichi, Japan.
  • Kobe T; Department of Gastroenterology, Tosei General Hospital, Seto, Aichi, Japan.
  • Hirano T; Department of Gastroenterology, Tosei General Hospital, Seto, Aichi, Japan.
  • Ichihara T; Department of Infectious Diseases, Tosei General Hospital, Seto, Aichi, Japan.
  • Takenaka H; Department of Gastroenterology, Tosei General Hospital, Seto, Aichi, Japan.
  • Niinomi T; Department of Gastroenterology, Tosei General Hospital, Seto, Aichi, Japan.
  • Umemura T; Infection Control Team, Tosei, General Hospital, Seto, Aichi, Japan.
  • Kuroiwa M; Department of Gastroenterology, Tosei General Hospital, Seto, Aichi, Japan.
IDCases ; 15: e00498, 2019.
Article in En | MEDLINE | ID: mdl-30775241
ABSTRACT

INTRODUCTION:

Kluyvera ascorbata is a gram-negative, catalase-positive, oxidase-negative, aerobic fermentative bacterium with flagella. This organism colonizes in the human body and its pathogenicity is extremely low; few clinical cases of K. ascorbata infection have been reported. PRESENTATION OF CASE We report on a patient who experienced severe sepsis and acute cholangitis due to K. ascorbata bacteremia and was treated with levofloxacin following antibiotic susceptibility testing. To our knowledge, this is the first case report of third-generation cephalosporins resistant K. ascorbata infection in Japan.

DISCUSSION:

Although this pathogen produces innate CTX-M type ß-lactamases and is generally resistant to first- and second-generation penicillins and cephalosporins, multi-drug resistant K. ascorbata infection, including ceftriaxone resistant infection has seldom been reported.

CONCLUSION:

The increase of drug-resistant pathogens is of concern; in such cases, rapid microbial identification and appropriate antibiotic selection are crucial for successful treatment.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: IDCases Year: 2019 Document type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: IDCases Year: 2019 Document type: Article Affiliation country: Japan